Under construction – not a live service
Sign in
Enrolling by invitationNo phase

Tests a walking training device for people recovering from stroke

Tests a mobile gait training device with sound cues in adults recovering from stroke.

Plain-language title generated from the registry record
Registry title: Gait Training for Hemiplegic Stroke Patients With Stationary Trainer

Key facts

Where
Taipei, TaiwanSee the site

AI summary: who the study is looking for

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 20 and older who have had a first stroke and can walk on level ground without assistive devices. It tests a new gait training device.

Age
20 years and older
Sex
All sexes can join.
Disease stage
First-ever stroke; Brunnstrom stage III to IV of the affected lower limb motor recovery; Functional Ambulation Category (FAC) level IV.

Main reasons for not taking part

  • Severe spinal cord injury or peripheral neuropathy
  • Unstable gait needing assistive devices, or high risk of falling
  • Severe problems with vision, hearing or thinking that prevent taking part in assessments
  • Lower limb fracture within the past 6 months

Read by machine on 9 November 2026.

Where in Taiwan

  • Cheng Hsin General HospitalTaipei, TaiwanNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Cheng-Hsin General Hospital
Trial code
NCT07395544
Record updated
9 February 2026
Original description
This study aims to evaluate the effectiveness of a novel mobile neurodevelopmental treatment (NDT) gait training device for patients recovering from stroke. Stroke is a major cause of disability worldwide, and many survivors experience difficulty with walking and require long-term rehabilitation. NDT is a widely used rehabilitation approach that focuses on improving motor control through techniques such as facilitation, inhibition, and key point control. However, traditional NDT gait training can be physically demanding for therapists and often limits the training intensity and duration for patients.Read full original descriptionShow less

Gait Training for Hemiplegic Stroke Patients: Employing a Stationary Neuro-developmental Trainer With Auditory Cues

This study aims to evaluate the effectiveness of a novel mobile neurodevelopmental treatment (NDT) gait training device for patients recovering from stroke. Stroke is a major cause of disability worldwide, and many survivors experience difficulty with walking and require long-term rehabilitation. NDT is a widely used rehabilitation approach that focuses on improving motor control through techniques such as facilitation, inhibition, and key point control. However, traditional NDT gait training can be physically demanding for therapists and often limits the training intensity and duration for patients.

To address these challenges, this study introduces an automated NDT gait training device that replicates therapist techniques using mechanical support and sensory feedback. The system uses bilateral dynamic assistance at the waist, auditory cues, and wearable inertial measurement units (IMUs) to help patients practice natural and symmetric walking patterns on the ground, instead of being restricted to treadmill training. The IMUs also provide objective gait data to assess improvement in gait symmetry, pelvic rotation, walking speed, and cadence.

The primary goal is to assess changes in these gait parameters before and after NDT-based intervention. The study plans to enroll 40 adult stroke survivors (aged 20 and older) over a 3-year period starting from May 1, 2024.

Inclusion: Age ≥ 20 years, first-ever stroke, with Brunnstrom stage III to IV of the affected lower limb motor recovery; Functional Ambulation Category (FAC) level IV; Ability to ambulate on level ground without assistive devices; Ability to understand instructions and cooperate with assessments.

Exclusion: Severe impairment in vision, hearing, or cognition, making them unable to comply with assessments; Presence of severe spinal cord injury or peripheral neuropathy; Unstable gait requiring assistive devices, or participants at high risk of falling; Lower limb fracture within the past 6 months.

ClinicalTrials.gov NCT07395544